Search
Search
Share
Corporate Responsibility
Dividend
Result
Employees
Sales
Divisions
Strategy
Executive Board
Home
·
|
Merck Group
·
|
Contact
·
|
Deutsch
·
|
Sitemap
·
|
Search
Sitemap
Transformation on track
Letter from
Karl-Ludwig Kley
Executive Board
Financial Calendar
Merck Group
Merck Serono
Consumer Health
Performance Materials
Merck Millipore
Group Management Report
Fundamental Information about the Group
Divisions
Merck Serono
Consumer Health
Performance Materials
Merck Millipore
Objectives and strategies
Principles and Group strategy
Strategic initiatives
Business strategies of the divisions
Strategic financial and dividend policy
Internal management system
Group and Division KPIs
Capital Market-Related Parameters
Other Performance Measures
Corporate Responsibility
Society
Employees
Products
Environment
Research and Development
Merck Serono
Merck Serono pipeline
Overview compounds
Consumer Health
Performance Materials
Merck Millipore
Collaborations
Merck Shares
Share data
Shareholder
Report on Economic Position
Macroeconomic environment
Review of forecast
Course of business and economic position
Business development
Expenses
Result
Assets and liabilities
Business free cash flow
Rating
Overall assessment
Merck Serono
Business development
Regions
Major products
Expenses
Result
Business Free Cash Flow
Consumer Health
Business development
Regions
Expenses
Result
Business Free Cash Flow
Performance Materials
Business development
Regions
Expenses
Result
Business Free Cash Flow
Merck Millipore
Business development
Regions
Business units
Expenses
Result
Business Free Cash Flow
Corporate and Other
Report on Risks and Opportunities
Business-related risks and opportunities
Risks and opportunities of product quality and availability
Financial risks and opportunities
Legal risks
Risks and opportunities in human resources
Risks and opportunities of information technology
Environmental and safety risks
Report on Expected Developments
Merck Group
Merck Serono
Consumer Health
Performance Materials
Merck Millipore
Summary
Capital and shares
Subsequent Events
Corporate Governance
Statement on Corporate Governance
Merck KGaA
Statement of Compliance
Compensation report
Executive Board
Supervisory Board
Ownership of shares
Corporate Governance Practices
Principles
Values and compliance
Procedures of the corporate bodies
Executive Board
Supervisory Board
Board of Partners of E. Merck KG
Report of the
Supervisory Board
Objectives of the Supervisory Board
Financial Statements
Income Statement
Comprehensive Income
Balance Sheet
Cash Flow Statement
Changes in Net Equity
Notes
General
Company information
Reporting principles
Scope of consolidation
Changes in the scope of consolidation
Acquisitions and divestments
Accounting policies
Accounting and measurement principles
Management judgments and sources of estimation uncertainty
Consolidation methods
Currency translation
Recognition of sales and other revenue
Research and development
Financial instruments: Principles
Financial instruments: Categories and classes of financial instruments
Financial instruments: Derivative and hedging relationships
Other non-financial assets and liabilities
Inventories
Intangible assets
Property, plant and equipment
Leasing
Deferred taxes
Provisions
Provisions for pensions and other post-employment benefits
Notes to the consolidated income statement
Sales
Royalty, license and commission income
Cost of sales
Marketing and selling expenses
Royalty, license and commission expenses
Administration expenses
Other operating expenses and income
Research and development
Amortization of intangible assets
Financial result
Income tax
Non-controlling interest
Earnings per share
Notes to the balance sheet
Cash and cash equivalents
Current financial assets
Trade accounts receivable
Inventories
Other assets
Tax receivables
Intangible assets
Property, plant and equipment
Non-current financial assets
Financial liabilities
Trade accounts payable
Other liabilities
Tax liabilities
Provisions
Provisions for pensions and other post-employment benefits
Equity
Segment reporting
Information by division/country and region
Information on segment reporting
Notes to the consolidated cash flow statement
Net cash flows from operating activities
Net cash flows from investing activities
Business free cash flow
Other disclosures
Derivative financial instruments
Management of financial risks
Other disclosures on financial instruments
Capital management
Contingent liabilities
Other financial obligations
Personnel expenses/Headcount
Material costs
Auditors' fees
Corporate governance
Companies opting for exemption under section 264 (3) HGB or section 264b HGB
Related-party disclosures
Executive Board and Supervisory Board compensation
Information on preparation and approval
Subsequent events
List of shareholdings
Auditor's Report
Business Development 2009-2013
CHART GENERATOR
Interactive chart tool
SERVICES
Recommend page
Print page
Order online
Glossary
Downloads
Home
Transformation on track
Group Management Report
Corporate Governance
Financial Statements
Notes
Business Development 2009-2013
made by Nexxar - your next annual report online!, Vienna - Austria
